Multiple Myeloma Q&A: IVIG, CAR-T, Bispecifics, Vitamins, GLP-1s & Vaccines

Description

The faculty of the HealthTree Houston Myeloma Roundtable (October 24, 2026), including Drs. Krina Patel, Meera Mohan, William Matsui, and Sarvari Yellapragada, answer audience questions about living with multiple myeloma. Topics include vitamin D, B12, and supplements, how to support your immune system and prevent infections after transplant, CAR-T, and bispecific treatment, GLP-1 medications, valacyclovir dosing with kidney disease, whether bispecifics rule out CAR-T, in vivo CAR-T, IVIG downsides and allergic reactions, stress, red light therapy and functional medicine, flu and RSV vaccines, CELMoDs before CAR-T, what causes myeloma, family risk, and AI in myeloma care.